Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Veracyte, Inc. (VCYT)  
$20.97 0.82 (3.76%) as of 4:30 Fri 6/14


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 82,823,000
Market Cap: 1.74(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $18.92 - $29.92
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  484
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Veracyte is a genomic diagnostics company. Co. develops tests that address clinical needs in the diagnosis, prognosis and treatment of cancer and other diseases. Co. provides tests in: thyroid cancer via its Afirma Genomic Sequencing Classifier (GSC) and Xpression Atlas; prostate cancer via its Decipher Biopsy and Radical Prostatectomy Genomic Classifiers; breast cancer via its Prosigna Breast Cancer Assay; lung cancer via its Percepta GSC and Percepta Nasal Swab Test; interstitial lung diseases including idiopathic pulmonary fibrosis via its Envisia Genomic Classifier; bladder cancer via its Decipher Bladder Genomic Classifier; and colon cancer via its Immunoscore Colon Cancer Test.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 21,779 31,779 114,409 523,205
Total Sell Value $459,589 $703,188 $3,171,383 $13,848,977
Total People Sold 2 3 4 6
Total Sell Transactions 5 6 15 32
End Date 2024-03-17 2023-12-15 2023-06-16 2022-06-16

   
Records found: 551
  Page 6 of 23  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Anderson Bonnie H Executive Chairwoman   •       •      –    2022-06-02 4 D $18.23 $37,226 D/D (2,042) 67,045     -
   Anderson Bonnie H Executive Chairwoman   •       •      –    2022-05-01 4 D $20.47 $15,066 D/D (736) 85,952     -
   Kennedy Giulia C Chief Scientific & Med Officer   •       –      –    2022-03-04 4/A AS $24.91 $578,535 D/D (23,033) 61,361     -
   Kennedy Giulia C Chief Scientific & Med Officer   •       –      –    2022-03-04 4 AS $24.91 $577,783 D/D (23,003) 61,391 3%     
   Kennedy Giulia C Chief Scientific & Med Officer   •       –      –    2022-03-04 4 OE $5.98 $26,354 D/D 4,407 84,394     -
   Chambers Rebecca Chief Financial Officer   •       –      –    2022-03-03 4 A $0.00 $0 D/D 20,728 54,728     -
   Stapley Marc Chief Executive Officer   •       •      –    2022-03-03 4 A $0.00 $0 D/D 56,537 103,808     -
   Anderson Bonnie H Executive Chairwoman   •       •      –    2022-03-03 4 A $0.00 $0 D/D 17,667 86,688     -
   Kennedy Giulia C Chief Scientific & Med Officer   •       –      –    2022-03-03 4 A $0.00 $0 D/D 42,412 79,987     -
   Nova Tina Susan President, CLIA U.S.   •       –      –    2022-03-03 4 A $0.00 $0 D/D 56,546 76,988     -
   Kennedy Giulia C Chief Scientific & Med Officer   •       –      –    2022-03-02 4 D $27.84 $287,782 D/D (10,337) 37,575     -
   Nova Tina Susan President, CLIA U.S.   •       –      –    2022-03-02 4 D $27.84 $297,749 D/D (10,695) 20,442     -
   Anderson Bonnie H Executive Chairwoman   •       •      –    2022-03-02 4 D $27.84 $125,865 D/D (4,521) 69,021     -
   Wygant Jonathan VP, Chief Accounting OfficerOf   •       –      –    2022-03-01 3 IO $0.00 $0 D/D 0 12,000 -12%     
   Mcguire Annie SVP, General Counsel   •       –      –    2022-02-28 4 A $0.00 $0 D/D 22,855 22,855     -
   Jones Evan/ Fa Director   –       •      –    2022-01-11 4 OE $4.00 $20,000 D/D 5,000 43,720     -
   Nova Tina Susan President, CLIA U.S.Officer   •       –      –    2022-01-06 3 IO $0.00 $0 D/D 0 30,000 -48%     
   Eastham Karin Director   –       •      –    2021-12-17 4 AS $45.00 $225,000 D/D (5,000) 8,720 -55%     
   Eastham Karin Director   –       •      –    2021-12-17 4 OE $12.12 $60,600 D/D 5,000 13,720     -
   Anderson Bonnie H Executive Chairwoman   •       •      –    2021-12-09 4 OE $8.86 $99,994 D/D 11,286 73,542     -
   Kennedy Giulia C Chief Scientific & Med Officer   •       –      –    2021-12-07 4 AS $39.69 $246,356 D/D (6,125) 47,912 -42%     
   Kennedy Giulia C Chief Scientific & Med Officer   •       –      –    2021-12-07 4 OE $24.69 $154,481 D/D 6,125 54,037     -
   Kennedy Giulia C Chief Scientific & Med Officer   •       –      –    2021-12-06 4 AS $35.37 $332,784 D/D (9,232) 47,912 -38%     
   Kennedy Giulia C Chief Scientific & Med Officer   •       –      –    2021-12-06 4 OE $5.98 $102,135 D/D 8,156 57,144     -
   Kennedy Giulia C Chief Scientific & Med Officer   •       –      –    2021-12-02 4 D $39.22 $35,769 D/D (912) 48,988     -

  551 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 6 of 23
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed